Alfred Kingsley - AGE Old Chairman of the Board

AGEDelisted Stock  USD 0.74  0.01  1.37%   

Chairman

Mr. Alfred D. Kingsley is Chairman of the Board of the Company. Kingsley was general partner of Greenway Partners, L.P., a private investment firm, and President of Greenbelt Corporationration, a business consulting firm, since 1993. Additionally, Mr. Kingsley was Senior VicePresident of Icahn and Company and its affiliated entities for more than 25 years. Mr. Kingsley has served as Chairman of AgeX parent company BioTime, Inc. since 2009 and Chairman of OncoCyte Corporationration since 2009. He is also a member of the Board of Directors of Asterias Biotherapeutics, having served as the companys Chairman from 2012 to 2016
Age 76
Phone510 671 8370
Webhttps://www.agexinc.com
Kingsley holds a BS degree in economics from the Wharton School of the University of Pennsylvania, and a J.D. degree and LLM in taxation from New York University Law School.

AGE Old Management Efficiency

The company has Return on Asset of (0.8188) % which means that on every $100 spent on assets, it lost $0.8188. This is way below average. AGE Old's management efficiency ratios could be used to measure how well AGE Old manages its routine affairs as well as how well it operates its assets and liabilities.
AGE Old has 4.37 M in debt with debt to equity (D/E) ratio of 0.75, which is OK given its current industry classification. AGE Old has a current ratio of 0.19, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for AGE to invest in growth at high rates of return.

Similar Executives

Found 4 records

CHAIRMAN Age

Harlan MDLyra Therapeutics
72
Quang PhamCadrenal Therapeutics, Common
60
Vlad CoricBiohaven Pharmaceutical Holding
50
Declan DooganBiohaven Pharmaceutical Holding
68
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. AgeX Therapeutics, Inc. was incorporated in 2017 and is based in Alameda, California. Agex Therapeutics operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 5 people. AGE Old (AGE) is traded on NASDAQ Exchange in USA and employs 4 people.

Management Performance

AGE Old Leadership Team

Elected by the shareholders, the AGE Old's board of directors comprises two types of representatives: AGE Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AGE. The board's role is to monitor AGE Old's management team and ensure that shareholders' interests are well served. AGE Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AGE Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
EunJae CPA, Chief Officer
Alfred Kingsley, Chairman of the Board
Judith Segall, Secretary
Michael West, Chief Executive Officer, Founder, Director
Aubrey Grey, Vice President - New Technology Discovery
Gregory Bailey, Independent Chairman of the Board
Ivan Labat, Chief Information Officer
Joanne Hackett, Interim Board
Hal Sternberg, Vice President - Research
Nafees MD, Chief Officer
Andrea Park, Chief Financial Officer
Annalisa Jenkins, Independent Director
Michael May, Independent Director

AGE Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AGE Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Consideration for investing in AGE Stock

If you are still planning to invest in AGE Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AGE Old's history and understand the potential risks before investing.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Correlations
Find global opportunities by holding instruments from different markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Stocks Directory
Find actively traded stocks across global markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets